Search Results 281-290 of 2812 for ⚔[광고텔레:ADSFIX01] 바카라커뮤니티광고 대포장홍보 파워볼솔루션광고 개인장업체 카지노API 구글머니상홍보 노래방광고 토토디비광고 구글상단도배광고 상위노출대행⚔
Necuparanib has been re-engineered from heparin to have much lower blood thinning activity while keeping the anti-tumor activity. The investigators are testing ...
The purpose of this study is to retrospectively review experiences with thoracic endovascular aortic repair (TEVAR) of blunt traumatic thoracic aortic injury ( ...
The Mayo Clinic Kern Center for the Science of Health Care Delivery's multidisciplinary faculty guides research on the delivery of evidence-based, ...
This 8-week randomized, open-label evaluation will examine the acute safety and tolerability of 4 different dosing regimens of Acthar to inform dose selection ...
The purpose of this research is to follow people with adrenal disorders in order to make conclusions about the natural history of a particular adrenal disease ...
The purpose of this study is to assess genetic predictors of chemotherapy-related amenorrhea in breast cancer survivors of both European and non-European ...
About this study. This trial is a multi-center, adaptive, randomized, double-blind, placebo- and active- controlled, parallel group, phase 2 study in ...
About this study. The purpose of this registry is to evaluate procedure characteristics and short and long-term patient outcomes following shape-sensing ...
This is a single arm, open-label, multi-center, phase 1/2 study, to determine the safety and efficacy of KTE-X19, an autologous anti-CD19 chimeric antigen ...
About this study. The purpose of this study is to assess long-term safety data of GED-0301 for a period of up to 208 weeks in adult subjects (i.e., ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.